Transgene S.A.
TNG.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.10 | 0.07 | -0.01 | 0.09 |
| FCF Yield | -16.20% | -7.55% | -19.55% | -13.16% |
| EV / EBITDA | -5.80 | -4.52 | -4.73 | -9.25 |
| Quality | ||||
| ROIC | -59.44% | -48.00% | -42.83% | -40.41% |
| Gross Margin | 0.00% | -529.34% | -52,460.87% | -346.89% |
| Cash Conversion Ratio | 0.94 | 0.33 | 1.10 | 2.65 |
| Growth | ||||
| Revenue 3-Year CAGR | -21.74% | -12.46% | -23.03% | -18.52% |
| Free Cash Flow Growth | -172.73% | 66.38% | -10.19% | 4.28% |
| Safety | ||||
| Net Debt / EBITDA | -0.63 | 0.34 | 0.82 | 1.07 |
| Interest Coverage | -23.48 | -13.90 | -36.58 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 1,770.94 | -9.72 | 8,018.19 | -29.18 |